Tài liệu, văn bản bạn tìm kiếm
Subcutaneous metastasis, Epigenetic phenotyp, Comprehensive medical assessment, Especially metastasis, Advanced retinoblastoma, 18 F-FDG, Collect tumor tissue, Proximal gastric cancer, Triplet chemotherapy plus bevacizumab, Therapeutic modulators, Glucose analogue, Economic impact study, anti-Epidermal growth factor receptor, Elective neck dissection, Splenic hilar lymph node, Non-obligate precursor, Therapeutic candidates, Clinical benefit, Finding molecular biomarkers, Gastroesophageal junction cancer, SUVmax value, Early-stage oral squamous cell carcinoma, Secondary angiosarcoma, Spatial UBE2N protein, Spleen-preserving lymphadenectomy, Smoking cessation intervention, Invasion depth, Pan-cancer perspective, Health transition, Mediastinal lymph node dissection, Indicates genomic instability, Occult lymph node metastasis, Spontaneous bleeding, Cigarette smokers, Cancer disease progression, Standardised incidence rate ratios, Recurrent prostate cancer, Siewert type, The surveillance, Radiation-related angiosarcoma, Intratumoural bleeding, King Hussein Cancer Center, Salvage radiation therapy, Cancer de-differentiation, Diagnostic potentials, Janus kinase 2, Russian general populations, Bag-1, Classical test theory, High-risk prostate cancer, Prostate cancer displays, Debilitating disease, Bad phosphorylation, Cancer invasion, Adenoid cystic carcinoma, Minimal clinically important difference, Primary hypothesis, Pleural cavity, Raf kinase, Telephone case management, Colonoscopy history, Salivary gland neoplasms, Asbestos fibers, Insulin c-peptide, Treatment prediction, Colorectal cancer death, Lung adenosquamous carcinoma, Invasive breast cancer, IGF-1, Tumor grade, Lipidomic profile, Frequent lymphoproliferative disorder, Surgery resection, Smoldering multiple myeloma, Sentinel node metastases, Molecular therapy, Inhibitor PAI-1 play, Linked inpatient, Multiple lesions, CRC prognosis, N-Glycolyl GM3 ganglioside, Tumor thrombus, Pathways level associations, Co-morbid depression, Cumulative dose, BRAF-mutated CRC patients, Benign nodules, Non-sentinel node metastases, Medical benefits schedule data, Low tumor grade, Pathological subtypes, Disseminated cytokeratin-positive cells, High cumulative doses, Hypofractionated radiotherapy, Middle-income populations, Licensed drugs, Completion axillary lymph node dissection, SCC-predominant ASC, Oncogenic signaling, Somatosensory disorders, Plasma samples, Non-metastatic nasopharyngeal carcinoma, Electronic databases, Check point inhibitors, Cisplatin-related toxicities, Prostate cancer metastasis, EGFR-activating mutations, Inflammatory factor, Novel plasma markers, Gynecological cancer, Bowel perforation, Cancer microbiota, Serum marker, Nuclear encoded mitochondrial gene, Metastatic anal canal tumour, Single cancer cells, Female reproductive tract, Neuromuscular adaptation, Pathogenic germline mutations, Phyllodes tumors, Colorectal adenomas, Ca2+ release, Fluorescence cytochemical labeling, Solitary metastasis, Functional brain networks, Thereby placing MNRR1 upstream, FFPE tissue, Intratumour heterogeneity, Monocarboxylic polyether antibiotic, T cell activation score, EGFR pathway, Pelvic node, Targeted capturebased NGS, 3D in vitro model, Autologous stem cell transplant, Potential chemotherapy drug, Local excision, Clonal mutations, CD8+ T cell activation, TET2 mutation, Locally advanced pancreatic cancer, Fibrillar actin, RNA-based multigene, Hepatic cell, Radiation boost, CNV detection, Salinomycin inhibited cell growth, Establish treatment strate, University of Gondar Hospital, Melanoma cell invasion, External beam radiation therapy, Tet oncogene family member 2, Non-cancerous hepatic, Irreversible electroporation, Truncal mutations, Treatment monitoring, Eliminate tumor cells, Salinomycin action, Non-multifocal, Poor health-related QOL, Drug-induced increase, Unsatisfactory treatment outcomes, Blended cognitive behaviour therapy, Pooled hazard ratios, Uveal melanoma, Time trade off, Digital droplet PCR, Target-next generation sequencing, Somatic evolution, Programmed cell death 1 receptor, Routine cytogenetic analysis, SWI/SNF chromatin remodeling complex, Inducing chronic inflammation, Histone deacetylase inhibitors, Functional tumor suppressor, Response prediction, Population-based cancer registries, CCNE1 gains, Increased tumor risk, Oncology service, Circulating microRNAs miR-331, Precisely placed chromosomal breakpoints, Anti-tumoral responses, Heme iron, Oncogenic Ras, Stem-loops, Health services financing, TGF-β pathway, Pediatric cancer survivorship, ARID1B haploinsufficiency, Net survival, Acral ischemia, Inferior vena cava thrombus, Breast microbiota, Ivor Lewis esophagectomy, Human ovarian cancer, Distant metastatic disease, Health care survey, Kypho-IORT, Genetic association study, Anatomical subsite, Cisplatin-resistant HNSCC treatment, Non-B motifs, Symptom screening, Survival after recurrence, Small vessel vasculitis, Clinical implication, Community-based healthcare organisations, Chromosomal abnormality, Glioma therapy, Left transthoracic esophagectomy, Intraoperative radiotherapy, Septin 9, IVC tumor thrombus, Cisplatin-resistant HNSCC cells, DNA secondary structures, Locoregionally advanced nasopharyngeal carcinoma, Apoptosis-Inducing Factor Mitochondrion-associated 3, Cement augmentation, Matrix metalloproteinase 19, Intraperitoneal drug delivery, Cancer genomes, Triweekly cisplatin regimens, Vertebral metastases, Carbohydrate antigen, Cancer mutations, Zinc-dependent endopeptidases, Rat xenograft, Sigma-2 receptor, No-touch, Laparoscopic-assisted pylorus-preserving gastrectomy, Acute toxicities, Tumour reoxygenation, Drug rotation, Genome rearrangements, Multifunctional glycoprotein, Lung metastases.HER-2 gene, Single nucleotide variation, Cardiac sarcoma, TMEM97 agonist PB221, Pathological stages, Treatment Simulation, Loco-regional recurrence, Castration-sensitive prostate cancer, Small hepatocellular carcinoma, Hepatic metastases, Alternative drug, Machine learning models, Intraparotid node metastasis, Opportunistic screening, Stromal tumorinfiltrating lymphocytes, Richter syndrome, Undifferentiated pleomorphic sarcoma, Human recombinant, Cancer vaccines, Summary receiver operative curve, Acinic cell carcinoma, Ocular melanoma, Pancreatic duct adenocarcinoma, Organised screening, Squamous cell carcinoma of the penis, Biomarker of response, C-met inhibitor, Richter transformation, Synthetic long peptides, Identifying hypoxic, Massive ascites, Melanoma brain metastases, Outcome prediction, High-grade transformation, Abiraterone acetate plus prednisone, Endurance exercise, Fribourg cancer registry, Penile carcinoma-specific survival, Toll-like receptor 9, CA-4, BTK inhibitor, C-met receptor, History of prior cancer, Chronic hypoxia, Pediatric medulloblastoma, F-box protein family, Basaloid squamous cell carcinoma, Forced running wheels, Inadequate oral intake, Aberrantly expressed microRNAs, Human papilloma virus antigen E7, DR5 dependent apoptosis, Oncomine database, Prior cancer, Solid tumor progression, First-line, Cell junctions, Radiation-induced intestinal fibrosis, Tumor biomarker, Endoscopic feature, Aspartic transaminase, Molecular risk scores, Intracranial aneurysms formation, Human epidermal receptor 2, Frail patients, Fibroblast growth factor 2, Murine mammary tumor, TTF-1 expression, Hepatic injury, EP4 receptor, Sorting nexin 27, Interfraction motion, Non-randomized phase II, Perfusion CT, Chronic comorbid pathologies, Pancreatic neoplasm, Normal neural tissue plasticity, Cell division cycle associated 2, Cancer screening uptake, Non-Hodgkin, Endocrine treatment, Aberrant methylation, Stage IV lung adenocarcinoma, Mouse embryogenesis, Mutation profiling, VEGF receptors, Nonruptured cerebral aneurysm, Hypothesized TNM staging system, Gene expression measurement, Multiple cancer types, Squamous cell carcinomas, Familial ovarian cancer, Cancer-related stigma attracts, Distant omental metastases, NTRK2-encoded protein, Cauda equine, EGFR-sensitizing mutations, Stem-like cells, Lung cancer model, Topoisomerase I gene, Adaptive design, TNM staging system, Tumor evolution, EGFR exon 20 insertion mutations, Cranial-caudal, Favoring endocrine treatment, Estradiol metabolism, Bladder urothelial carcinoma, Cancer stigma, Branched chain amino acid transaminase 1, Polysome profiling, Prenylated Rab acceptor 1 domain family, Nanos sequences, Bayesian adaptive, Non-complete response, NTRK1 fusion, Mutated BRCA1/2 genes, Heterogeneous behavior, YAP inhibits growth, Western blot analysis, Mastermind-like transcriptional coactivator 3, DNA methyltransferase 1, Maximal tolerated dose, Nanos paralogs, LIHC transcriptomics, Antibody therapeutics, Several malignant tumors, Despite Neo-Bioscore, Overall surviva, Phase angle, Hep-2 laryngeal cancer cells, Co-immunoprecipitation analysis, Transcriptional network, Serum chitinase activity prognosticates metastasis, Remarkably universal, Valproic acid-induced amphiregulin, Preclinical model, Stage-specific biomarkers, Nodal status, Model-based design, Penile squamous cell carcinoma, Lateral lymph node metastasis, Temozolomide treatment, Ganglionic PSMA expression, Tumor supressor gene, Pig model, Rule-based design, Human glioma cells, Pairwise contrasts, DNA aneuploidy, Kinase-impaired, Inter-alpha-trypsin inhibitor heavy chain 4, Ependymal tumor, PI3 kinase, Neoplasm metastasis, Significance analysis, Individual cancer, SDS gel electrophoresis, Benchmark treatment, Clinical mutational profiling, Meta-analysis aims, Invasive front, Linear modelling, Molecular features facilitate tumor grading